Metformin for Gestational Diabetes Mellitus

Introduction to Gestational Diabetes Management

The American Diabetes Association recommends that insulin is the first-line pharmacologic agent for gestational diabetes mellitus (GDM), and metformin should only be considered as a second-line alternative in specific circumstances when insulin cannot be used safely or effectively 1, 2, 3

Lifestyle modification, including medical nutrition therapy with individualized carbohydrate management and physical activity, is the initial treatment for gestational diabetes, with 70-85% of women with GDM achieving glycemic control with lifestyle modification alone 1, 2, 4
The American College of Obstetricians and Gynecologists recommends a minimum of 175g carbohydrate daily, 35% of a 2,000-calorie diet, and 20-50 minutes/day, 2-7 days/week of moderate intensity exercise 1, 2

Insulin remains the preferred first-line pharmacologic agent for GDM in the United States because it does not cross the placenta and has the most robust safety data 1, 2, 3, 4
Metformin can be used as a second-line alternative only in specific situations, such as when insulin cannot be used safely or effectively due to cost, language barriers, comprehension issues, or cultural influences 2, 3

Metformin readily crosses the placenta, resulting in umbilical cord blood levels equal to or higher than maternal levels, and long-term follow-up studies reveal concerning metabolic effects in offspring exposed to metformin in utero 1, 2, 3, 4
Children exposed to metformin in utero have been found to have higher BMI, increased obesity rates, higher weight-to-height ratios, and borderline increased fat mass 1, 2, 3

For women with polycystic ovary syndrome (PCOS) who were taking metformin to induce ovulation, metformin should be discontinued at the end of the first trimester once pregnancy is confirmed 7
There is no evidence-based need to continue metformin after conception in women with PCOS, and randomized trials show no benefit in preventing spontaneous abortion or GDM when continued 1, 2, 3, 5

The American Diabetes Association recommends a clinical algorithm for managing GDM, including diagnosing GDM, initiating lifestyle modification, starting insulin as first-line pharmacologic therapy if glycemic targets are not met, and considering metformin only if patient cannot use insulin safely/effectively 1, 2, 5